Natera

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). 

CEO
Stephen Leonard Chapman
CEOStephen Leonard Chapman
Employees
6,140
Employees6,140
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2003
Founded2003
Employees
6,140
Employees6,140

NTRA Key Statistics

Market cap
46.55B
Market cap46.55B
Price-Earnings ratio
-161.69
Price-Earnings ratio-161.69
Dividend yield
Dividend yield
Average volume
1.19M
Average volume1.19M
High today
$323.01
High today$323.01
Low today
$302.00
Low today$302.00
Open price
$320.89
Open price$320.89
Volume
2.47M
Volume2.47M
52 Week high
$323.01
52 Week high$323.01
52 Week low
$136.21
52 Week low$136.21

Stock Snapshot

With a market cap of 46.55B, Natera(NTRA) trades at $319.98. The stock has a price-to-earnings ratio of -161.69.

On 2026-08-07, Natera(NTRA) stock moved within a range of $302.00 to $323.01. With shares now at $319.98, the stock is trading +6.0% above its intraday low and -0.9% below the session's peak.

Trading activity shows a volume of 2.47M, compared to an average daily volume of 1.19M.

Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $323.01 and a low of $136.21.

Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $323.01 and a low of $136.21.

NTRA News

Investor's Business Daily 4h
What To Know About This IBD 50 Stock's 'Blowout' Quarter - Investor's Business Daily

...

What To Know About This IBD 50 Stock's 'Blowout' Quarter - Investor's Business Daily
TipRanks 5h
Natera price target raised to $340 from $325 at TD Cowen

TD Cowen raised the firm’s price target on Natera (NTRA) to $340 from $325 and keeps a Buy rating on the shares. The firm updated its model following Q2 results...

Simply Wall St 17h
Natera Posted Strong Q2 Results, Is The Stock Fully Priced?

Natera (NTRA) is back in focus after reporting Q2 2026 earnings on August 6, with revenue of US$752.75 million and a narrower net loss, alongside fresh regulato...

Natera Posted Strong Q2 Results, Is The Stock Fully Priced?

Analyst ratings

88%

of 24 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

More NTRA News

Nasdaq 22h
Natera Q2 Loss Narrows As Revenue Jumps; Raises FY26 Revenue Outlook

(RTTNews) - Natera Inc. (NTRA) on Thursday reported a narrower second-quarter loss as revenue surged 38% on higher testing volumes and pricing improvements. The...

Natera Q2 Loss Narrows As Revenue Jumps; Raises FY26 Revenue Outlook
TipRanks 1d
Natera’s SCORE-NHL Study Builds Long-Term Value in Lymphoma Monitoring

Natera Inc. (NTRA) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

Nasdaq 2d
Natera Files For Japan PMDA Approval Of Signatera Test In Bladder Cancer

(RTTNews) - Natera, Inc. (NTRA), a genetic testing company said on Wednesday that it has filed for approval in Japan to use its Signatera test as a companion di...

Natera Files For Japan PMDA Approval Of Signatera Test In Bladder Cancer
The Motley Fool 3d
Stanley Druckenmiller Put 18% of His $3.4 Billion Portfolio in This One Stock. Is Natera a Buy?

It can pay to track what the big investors on Wall Street are trading in quarterly 13-F filings. This quarter, legendary hedge fund manager Stanley Druckenmille...

Stanley Druckenmiller Put 18% of His $3.4 Billion Portfolio in This One Stock. Is Natera a Buy?
Simply Wall St 5d
Natera Stock Trades At A Premium To Sales After A 425% Return

Natera stock has delivered a very large 424.8% return over the past three years, yet the company currently screens as expensive on several valuation checks. Wit...

Natera Stock Trades At A Premium To Sales After A 425% Return

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.